Valproic Capsule, Liquid Filled
Product Images NDC 71610-906

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic (NDC 71610-906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (71610 0906 30)

Label (71610 0906 30)
Valproic Acid USP 250 mg oral liquid-filled capsules in a 30-capsule package. The label shows the NDC number 71610-906-30 and storage instructions to keep between 20-25 degrees Celsius. Manufactured by Catalent Pharma Solutions LLC in St. Petersburg, FL, and repackaged by Aphena Pharma Solutions in Cookeville, TN.*
FDA Label Image

Aphena (Aphena)

Aphena (Aphena)
FDA Label Image

The Following Structural Formula For Valproic Acid (pka 4.8) Has A Molecular Weight Of 144 And Occurs As A Colorless Liquid With A Characteristic Odor. It Is Slightly Soluble In Water (1.3 mg/ml) And (Image 1)

The Following Structural Formula For Valproic Acid (pka 4.8) Has A Molecular Weight Of 144 And Occurs As A Colorless Liquid With A Characteristic Odor. It Is Slightly Soluble In Water (1.3 mg/ml) And (Image 1)
Chemical structure of Valproic Acid showing its molecular connectivity with carbon (CH3, CH2, CH) and oxygen (O, OH) groups.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
This is a line graph comparing the percentage reduction in clinical parameter score (CPS) rate between Divalproex Sodium and placebo over a patient population percentage. The vertical axis shows the percentage reduction/increase in CPS rate, with improvement indicated upwards and worsening downwards, while the horizontal axis shows the percentage of patients. Two lines represent results for Divalproex Sodium (solid line) and placebo (dashed line).*
FDA Label Image

Figure 2 (Image 3)

Figure 2 (Image 3)
A line graph depicting the percentage reduction in CPS rate on the vertical axis against the percentage of patients on the horizontal axis. Two lines represent different doses: a solid line for high dose and a dotted line for low dose. The graph indicates patient outcomes ranging from worsening to improvement, with a midpoint denoting no change.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.